Ovid Therapeutics Inc. Income Tax Expense
Ovid Therapeutics Inc. (OVID) reported Income Tax Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-13
- Ovid Therapeutics Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for fiscal 2025 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for fiscal 2024 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for fiscal 2023 was $0.00.
- Ovid Therapeutics Inc. income tax expense (benefit) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $0.00 derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | $0.00 derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $0.00 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-13 | $0.00 derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $0.00 derived: sum of 3 quarters · filed 2024-05-14 | $0.00 derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-08 | $0.00 10-K · filed 2024-03-08 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | -$299.71K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | -$299.71K derived: sum of 3 quarters · filed 2023-08-04 | -$594.54K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-05 | -$299.71K derived: sum of 2 quarters · filed 2023-05-05 | -$594.54K derived: sum of 3 quarters · filed 2023-05-05 | $878.54K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | -$349.71K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$644.54K derived: sum of 2 quarters · filed 2023-03-13 | $828.54K derived: sum of 3 quarters · filed 2023-03-13 | $1.33M 10-K · filed 2023-03-13 |
| 2021-09-30 | -$294.83K 10-Q · filed 2022-11-08 | $1.18M derived: sum of 2 quarters · filed 2022-11-08 | $1.68M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.47M 10-Q · filed 2022-08-09 | $1.97M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $500.28K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 | |||
| 2017-12-31 | $0.00 10-K · filed 2018-03-29 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-06-13 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |